Leukemia can be a terrifying diagnosis for the more than 60,000 U.S. patients who are told they have this blood cancer every year. But the treatment for this disease can be just as frightening. For patients with certain forms ...
Feb 28, 2018
0
86
Stem cell transplants can cure patients with high-risk leukemia or lymphoma. Graft-versus-host disease (GVHD) is a potentially life-threatening side effect that occurs when the donor's immune cells attack the recipient's ...
Feb 5, 2018
0
34
The protein CD34 is predominantly regarded as a marker of blood-forming stem cells but it helps with migration to the bone marrow too.
Jan 22, 2018
0
65
Q: Does a bone marrow transplant change your DNA?
Jan 19, 2018
0
68
"Rampant" and "elderly" are words rarely used in the same sentence, unless we are talking of the percentage of people over 65 years old worldwide. Life expectancy has considerably increased, but it is still unknown how many ...
Jan 17, 2018
0
14
When a cancer patient receives a bone marrow transplant, time is of the essence. Healthy stem cells, which can restart the production of blood cells and immune system components after a patient's own are compromised, need ...
Jan 4, 2018
0
86
New clinical trial findings show that a therapeutic regimen involving transplantation of a person's own blood-forming stem cells can improve survival and quality of life for people with severe scleroderma, a life-threatening ...
Jan 3, 2018
0
25
A medication used to treat joint and skin conditions might also help people whose only hope of surviving cancer is receiving stem cells from a donor, according to research by a University of British Columbia scientist.
Dec 20, 2017
0
116
Daily low doses of the immune signaling protein interleukin-2 (IL-2) can safely benefit patients who develop chronic graft-versus-host disease following stem cell transplants, including particular benefit in pediatric patients ...
Dec 11, 2017
0
0
A group of investigators from Mayo Clinic and multiple academic research centers in Italy have identified a genetic model for predicting outcomes in patients with primary myelofibrosis who are 70 years or younger and candidates ...
Dec 9, 2017
0
1
